BACKGROUND/AIMS: Posttransplantation anemia (PTA) frequently occurs. We aimed to assess the prevalence of anemia at 6 months of transplantation in patients under different protocols of immunosuppression, and to determine the impact of anemia on long-term patient and graft survival. METHODS: We included 832 renal transplant recipients who were categorized at 6 months according to hemoglobin (Hb) level into two groups: the first group, with Hb >13 g/dl in males and >12 g/dl in females (group I, 385 cases); and the second group, with Hb <13 g/dl in males and <12 g/dl in females (group II, 447 cases). We compared the two groups regarding posttransplant complications as well as patient and graft survival. RESULTS: Although there was no significant difference between the two groups regarding acute rejection episodes, chronic allograft nephropathy was significantly higher in the anemic group. Other posttransplant medical complications were comparable in both groups. Graft survival was significantly higher in the nonanemic group. However, no difference in patient survival was detected. CONCLUSION: From this study, we can conclude that prevalence of PTA is high, especially in females and those receiving calcineurine inhibitors (CNI) and mycophenolate mofetil (MMF), and that it was associated with poorer graft outcome but with no effect on patient survival.
BACKGROUND/AIMS: Posttransplantation anemia (PTA) frequently occurs. We aimed to assess the prevalence of anemia at 6 months of transplantation in patients under different protocols of immunosuppression, and to determine the impact of anemia on long-term patient and graft survival. METHODS: We included 832 renal transplant recipients who were categorized at 6 months according to hemoglobin (Hb) level into two groups: the first group, with Hb >13 g/dl in males and >12 g/dl in females (group I, 385 cases); and the second group, with Hb <13 g/dl in males and <12 g/dl in females (group II, 447 cases). We compared the two groups regarding posttransplant complications as well as patient and graft survival. RESULTS: Although there was no significant difference between the two groups regarding acute rejection episodes, chronic allograft nephropathy was significantly higher in the anemic group. Other posttransplant medical complications were comparable in both groups. Graft survival was significantly higher in the nonanemic group. However, no difference in patient survival was detected. CONCLUSION: From this study, we can conclude that prevalence of PTA is high, especially in females and those receiving calcineurine inhibitors (CNI) and mycophenolate mofetil (MMF), and that it was associated with poorer graft outcome but with no effect on patient survival.
Authors: Claudio Rigatto; Patrick Parfrey; Robert Foley; Carol Negrijn; Carrie Tribula; John Jeffery Journal: J Am Soc Nephrol Date: 2002-04 Impact factor: 10.121
Authors: Mark M Mitsnefes; Mirna Subat-Dezulovic; Philip R Khoury; Jens Goebel; C Frederic Strife Journal: Am J Transplant Date: 2005-07 Impact factor: 8.086
Authors: Francesco Locatelli; Ronald L Pisoni; Christian Combe; Juergen Bommer; Vittorio E Andreucci; Luis Piera; Roger Greenwood; Harold I Feldman; Friedrich K Port; Philip J Held Journal: Nephrol Dial Transplant Date: 2004-01 Impact factor: 5.992
Authors: Georg Heinze; Christa Mitterbauer; Heinz Regele; Reinhard Kramar; Wolfgang C Winkelmayer; Gary C Curhan; Rainer Oberbauer Journal: J Am Soc Nephrol Date: 2006-02-15 Impact factor: 10.121
Authors: Pamala A Jacobson; David Schladt; William S Oetting; Robert Leduc; Weihau Guan; Arthur J Matas; Vishal Lamba; Roslyn B Mannon; Bruce A Julian; Ajay Israni Journal: Transplantation Date: 2011-02-15 Impact factor: 4.939
Authors: Leah A Krischock; Karlijn J van Stralen; Enrico Verrina; E Jane Tizard; Marjolein Bonthuis; György Reusz; Farida K Hussain; Augustina Jankauskiene; Gregor Novljan; Brankica Spasojević-Dimitrijeva; Ludmila Podracka; Vera Zaller; Kitty J Jager; Franz Schaefer Journal: Pediatr Nephrol Date: 2015-09-18 Impact factor: 3.714
Authors: Zhongli Huang; Turun Song; Lei Fu; Zhengsheng Rao; Dongyang Zeng; Yang Qiu; Xianding Wang; Libo Xie; Qiang Wei; Li Wang; Tao Lin Journal: Int Urol Nephrol Date: 2015-08-06 Impact factor: 2.370
Authors: Manuel Arias; Domingo Hernández; Luis Guirado; Josep M Campistol; Jaime A Sánchez Plumed; Ernesto Gómez; Miguel A Gentil; Carlos de Santiago Journal: Clin Kidney J Date: 2013-02-03